Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 38%. Looking ahead, revenue ...

Good afternoon, ladies and gentlemen, and welcome to Masimo's third-quarter 2024 earnings conference call. The company's press release is available at www.masimo.com. (Operator Instructions ...

Masimo Corporation MASI delivered adjusted earnings per share (EPS) of 98 cents in the third quarter of 2024, up 30.7% year ...

Masimo Corp. ( (MASI) ) has released its Q3 earnings. Here is a breakdown of the information Masimo Corp. presented to its investors. Masimo ...